| Study of the photodegradation of 2-bromophenol under UV and sunlight by spectroscopic, chromatographic and chemometric techniques A Jayaraman, S Mas, R Tauler, A de Juan Journal of Chromatography B 910, 138-148, 2012 | 36 | 2012 |
| Cancer cell metabolism as new targets for novel designed therapies IM De Mas, E Aguilar, A Jayaraman, IH Polat, A Martín-Bernabé, R Bharat, ... Future medicinal chemistry 6 (16), 1791-1810, 2014 | 33 | 2014 |
| Combined Analysis of NMR and MS Spectra (CANMS) M Chong, A Jayaraman, S Marin, V Selivanov, PR de Atauri Carulla, ... Angewandte Chemie International Edition 56 (15), 4140-4144, 2017 | 31 | 2017 |
| Exploring the Scope of [Pt2(4-FC6H4)4(μ-SEt2)2] as a Precursor for New Organometallic Platinum(II) and Platinum(IV) Antitumor Agents A Escolà, M Crespo, J Quirante, R Cortes, A Jayaraman, J Badia, ... Organometallics 33 (7), 1740-1750, 2014 | 30 | 2014 |
| Neutral and ionic platinum compounds containing a cyclometallated chiral primary amine: synthesis, antitumor activity, DNA interaction and topoisomerase I–cathepsin B inhibition J Albert, R Bosque, M Crespo, J Granell, C López, R Martín, A González, ... Dalton Transactions 44 (30), 13602-13614, 2015 | 29 | 2015 |
| Cyclopalladated primary amines: A preliminary study of antiproliferative activity through apoptosis induction J Albert, R Bosque, M Crespo, G García, J Granell, C López, MV Lovelle, ... European journal of medicinal chemistry 84, 530-536, 2014 | 26 | 2014 |
| On the stability and biological behavior of cyclometallated Pt (IV) complexes with halido and aryl ligands in the axial positions A Escolà, M Crespo, C Lopez, J Quirante, A Jayaraman, IH Polat, J Badia, ... Bioorganic & medicinal chemistry 24 (22), 5804-5815, 2016 | 21 | 2016 |
| Untargeted metabolomics reveals distinct metabolic reprogramming in endothelial cells co-cultured with CSC and non-CSC prostate cancer cell subpopulations A Jayaraman, P Kumar, S Marin, P de Atauri, F Mateo, TM Thomson, ... PloS one 13 (2), e0192175, 2018 | 16 | 2018 |
| MIDcor, an R-program for deciphering mass interferences in mass spectra of metabolites enriched in stable isotopes VA Selivanov, A Benito, A Miranda, E Aguilar, IH Polat, JJ Centelles, ... BMC bioinformatics 18 (1), 1-9, 2017 | 15 | 2017 |
| Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer A Achreja, T Yu, A Mittal, S Choppara, O Animasahun, M Nenwani, ... Nature Metabolism 4 (9), 1119-1137, 2022 | 13 | 2022 |
| p13CMFA: Parsimonious 13C metabolic flux analysis C Foguet, A Jayaraman, S Marin, VA Selivanov, P Moreno, R Messeguer, ... PLoS computational biology 15 (9), e1007310, 2019 | 13 | 2019 |
| Exploiting metabolic vulnerabilities after anti-VEGF antibody therapy in ovarian cancer D Glassman, MS Kim, M Spradlin, S Badal, M Taki, P Bhattacharya, ... iScience, 106020, 2023 | 1 | 2023 |
| Genomic loss in cancers enable discovery of metabolic targets for precision cancer therapy via multiobjective flux analysis and machine learning A Achreja, T Yu, A Mittal, S Choppara, N Meurs, O Animasahun, JH Jeon, ... Cancer Research 81 (13_Supplement), 236-236, 2021 | | 2021 |
| Stable isotope resolved analysis of HUVEC cells under normoxia and hypoxia (MTBLS412) MC A. Jayaraman, S. Marin, P. Atauri, V. Selivanov MetaboLights database, 2018 | | 2018 |
